Business Description
Immunotech Biopharm Ltd
ISIN : KYG4721A1004
Share Class Description:
HKSE:06978: Ordinary SharesCompare
Compare
Traded in other countries / regions
06978.Hong Kong IPO Date
2020-07-10Description
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | 0.11 | |||||
| Debt-to-Equity | 5.05 | |||||
| Debt-to-EBITDA | -1.34 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.9 | |||||
| 3-Year EPS without NRI Growth Rate | 22.8 | |||||
| 3-Year FCF Growth Rate | 24.1 | |||||
| 3-Year Book Growth Rate | -47.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.69 | |||||
| 9-Day RSI | 51.12 | |||||
| 14-Day RSI | 47.65 | |||||
| 6-1 Month Momentum % | -31.03 | |||||
| 12-1 Month Momentum % | -48.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.38 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -13.97 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -143.42 | |||||
| ROA % | -35.61 | |||||
| ROIC % | -31.03 | |||||
| ROC (Joel Greenblatt) % | -61.1 | |||||
| ROCE % | -51.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 12.71 | |||||
| Price-to-Tangible-Book | 16.62 | |||||
| EV-to-EBIT | -3.78 | |||||
| EV-to-EBITDA | -3.78 | |||||
| EV-to-FCF | -6.28 | |||||
| Earnings Yield (Greenblatt) % | -26.46 | |||||
| FCF Yield % | -17.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunotech Biopharm Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | |||
| EPS (TTM) (HK$) | -0.653 | ||
| Beta | -0.63 | ||
| Volatility % | 54.12 | ||
| 14-Day RSI | 47.65 | ||
| 14-Day ATR (HK$) | 0.167245 | ||
| 20-Day SMA (HK$) | 1.8065 | ||
| 12-1 Month Momentum % | -48.05 | ||
| 52-Week Range (HK$) | 1.5 - 5 | ||
| Shares Outstanding (Mil) | 514.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunotech Biopharm Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunotech Biopharm Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunotech Biopharm Ltd Frequently Asked Questions
What is Immunotech Biopharm Ltd(HKSE:06978)'s stock price today?
The current price of HKSE:06978 is HK$2.16. The 52 week high of HKSE:06978 is HK$5.00 and 52 week low is HK$1.50.
When is next earnings date of Immunotech Biopharm Ltd(HKSE:06978)?
The next earnings date of Immunotech Biopharm Ltd(HKSE:06978) is .
Does Immunotech Biopharm Ltd(HKSE:06978) pay dividends? If so, how much?
Immunotech Biopharm Ltd(HKSE:06978) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers